NMT Group PLC
26 September 2000
NMT GROUP PLC
AWARDED FIRST COMMERCIAL CONTRACT FROM PREMIER INC.
NMT Group PLC ('NMT'), the manufacturer of retractable devices to prevent
needlestick injury, announces that its subsidiary, New Medical Technology,
Inc., has been awarded its first commercial contract from Premier Purchasing
Partners, L.P., ('Premier'), the largest group purchasing organisation (GPO)
in the US.
The two-year contract follows a fifteen-month evaluation of NMT's 3cc safety
syringe, which allowed both designated and interested member hospitals the
opportunity to evaluate the products in their own care units. The product has
been chosen along with two other safety products from Retractable
Technologies, Inc. and Safety Medical Supply International. The three new
suppliers of safety products were evaluated against the yardsticks of meeting
an unmet need, delivering a full value benefit and providing opportunity for
improvement. Becton Dickinson previously enjoyed a sole-source contract for
needles and syringes with Premier and remain a supplier on the new multi-
source contract.
The potential value of the total contract for all four companies could be in
excess of $100 million over the duration of the agreement.
Premier serves approximately 1,900 hospitals and healthcare systems across the
country. The agreement puts New Medical Technology on the approved list of
suppliers to Premiers' members, affiliated hospitals and healthcare facilities
in the US.
Roy Smith, Chief Executive Officer of NMT, said:
'The award of this commercial should deliver significant revenues to the Group
and represents the achievement of one of the first key milestones we outlined
in our new business plan earlier this year.'
Enquiries:
NMT Group PLC Today: 0207 831 3113
Roy Smith, Chief Executive Officer Thereafter:01506 445000
Tony Fletcher, Chief Operating Officer, Finance Director
Financial Dynamics Tel: 020 7831 3113
Sophie Pender-Cudlip
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.